Bromodomain and extra-terminal protein inhibitor combination therapy
US-11464771-B2 · Oct 11, 2022 · US
This page is not indexed by search engines while we improve data quality.
Cho Robert patents
Cho Robert is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cho Robert |
| Total patents | 19 |
| First publication | Jun 29, 2017 |
| Latest publication | Oct 11, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-10960005-B2 · Mar 30, 2021 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-2021008056-A1 · Jan 14, 2021 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-10881655-B2 · Jan 5, 2021 · US
Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas
US-10849898-B2 · Dec 1, 2020 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-2020297727-A1 · Sep 24, 2020 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-2020155539-A1 · May 21, 2020 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-2020113905-A1 · Apr 16, 2020 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-10576075-B2 · Mar 3, 2020 · US
Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas
US-10548896-B2 · Feb 4, 2020 · US
Recent patents
Latest publications not already listed above.
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-10543213-B2 · Jan 28, 2020 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-2019240222-A1 · Aug 8, 2019 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-2019240223-A1 · Aug 8, 2019 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-10328077-B2 · Jun 25, 2019 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-2019083483-A1 · Mar 21, 2019 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-10166227-B2 · Jan 1, 2019 · US
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
US-2018125844-A1 · May 10, 2018 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-2018117030-A1 · May 3, 2018 · US
Bromodomain and extra-terminal protein inhibitor combination therapy
US-2017182025-A1 · Jun 29, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Celgene Quanticel Res Inc | 15 |
| Celgene Corp | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 19 |
| A61K2300/00 | 19 |
| A61K31/436 | 10 |
| A61K31/36 | 10 |
| A61K31/513 | 10 |